Contract Notice Detail

Summary Information Summary Information Base Total Price: 580,495.600000 Euro   Forbid offers above base price:   Request Reference: PH-111014723   Request Name: Aquisição de medicamentos ALEXION PHARMA SPAIN, S.L. - Sucursal em Portugal   Phase: Tendering Phase State: Awarded Description: Aquisição de medicamentos ALEXION PHARMA SPAIN, S.L. - Sucursal em Portugal   Procedure Type: VortalGOV - Direct Award (ECP)   Object of the Contract Object of the Contract Type of Contract: Supplies Acquisition   Main Object CPV Main Category: Estrada do Forte do Alto do Duque 1449-005 Lisboa PORTUGAL   CPV Main Vocabulary 33600000-6 - Pharmaceutical products   CPV Supplementary Vocabulary   Additional Classifications List   Scheduling Scheduling Request online publishing date: 9/21/2023 11:05 AM (UTC +1 hour)   Due datetime for receiving replies: 9/22/2023 5:00 PM (UTC +1 hour)   Financial Settings Financial Settings Define Advance Payments? No   Define Warranties? No   Contract Documents Contract Documents Document Name Description Doc Classification Anexo II.xlsx Anexo II.xlsx Download Cader encar 111014723 alexion.pdf Cader encar 111014723 alexion.pdf Download Convite 111014723 alexion.pdf Convite 111014723 alexion.pdf Download Object of contract This contract is subject to renewal? No   The procurement is related to a project and/or programme financed by European Union funds? No   Legal, economic, financial and technical information The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons? No   Questionnaire Questionnaire     1   Questionário   1.1         Main Section   1.1.1         Articulado * (Os valores indicados não incluem o IVA) Solicitou requisitos adicionais nesta lista de preços.           Preço Total Total without VAT0,000000 EUR             Cód. Artigo Referência Interna Descrição Qt Unidade Preço Unitário Preço Total           Reference1 DescriptionAquisição de medicamentos           Reference1 Internal Reference DescriptioneCULIzumab 300 MG SOL INJ FR 30 ML IV Qty170,000000 UnitFR Price per Unit Total Evaluation Evaluation Evaluation General Settings Evaluation General Settings Evaluation guideline MostEconomicallyAdvantageousTender   Evaluation Method Manual   Evaluation Items Evaluation Items Name Lot Critérios De Avaliação   Critérios de Adjudicação     Peso (%)**   1   Preço 100   Define tie breaking rules? YesNo     Public Messages Public Messages Type Reference Subject Date No items found...